BridgeMD
Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age: RhinoPOC RCT
EU CTIS ID: 2024-512561-13-00
What this study is testing
The main objective of the study is to determine whether children aged 6 months to 2 years, who suffer from acute wheezing that has been shown to be rhinovirus- or other picornavirus-induced (using point-of-care test at the emergency department) benefit from oral prednisolone.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age 6 months to 2 years
- Acute wheezing diagnosed by an emergency department physician
- Positive rhinovirus- or other picornavirus in nasal swap
- Arrival at the hospital within the past 6 hours
- Salbutamol treatment at the emergency department
You likely can't join if
- Need for immediate resuscitation
- Active chickenpox infection
- Suspected foreign body in respiratory tract
- Immunosuppressive treatment
- Systemic glucocorticoid treatment within the previous 14 days
- Allergy to glucocorticoids
See the full eligibility criteria
- Age 6 months to 2 years
- Acute wheezing diagnosed by an emergency department physician
- Positive rhinovirus- or other picornavirus in nasal swap
- Arrival at the hospital within the past 6 hours
- Salbutamol treatment at the emergency department
- Need for immediate resuscitation
- Active chickenpox infection
- Suspected foreign body in respiratory tract
- Immunosuppressive treatment
- Systemic glucocorticoid treatment within the previous 14 days
- Allergy to glucocorticoids
- Need for immediate transfer to an intensive care unit
- Suspected pneumonia in auscultation
- Suspected serious bacterial infection
- Positive RS-virus in nasal swab
- Positive SARS-CoV-2 in nasal swab
- Positive Mycoplasma pneumoniae in nasal swab
- Positive Bordetella pertussis in nasal swab
- Chickenpox exposure within the previous 14 days
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.